8-KEarnings & ResultsExhibits & Filings

DEXCOM INC 8-K Report, Financial Results (Apr 29, 2021)

Filed April 29, 2021For Securities:DXCM

Summary

DexCom, Inc. (DXCM) filed an 8-K on April 29, 2021, to report its financial results for the first quarter ended March 31, 2021. The key takeaway for investors is the positive financial performance announced, which was detailed in an accompanying press release furnished as an exhibit to the filing. This report serves to inform the market of the company's operational and financial standing at the close of the first quarter of 2021. While the 8-K itself is a regulatory filing primarily referencing the press release, it signals the company's proactive communication of its financial health. Investors should refer to the furnished press release (Exhibit 99.01) for specific details on revenue, profitability, and any forward-looking statements or guidance provided by DexCom. The filing confirms the release of this crucial financial data, allowing the market to assess the company's performance against expectations and historical trends.

Key Highlights

  • 1DexCom announced its financial results for the first quarter ended March 31, 2021, via an 8-K filing on April 29, 2021.
  • 2The primary information regarding the financial results is contained within a press release furnished as Exhibit 99.01 to the 8-K.
  • 3The filing includes information on the company's "Results of Operations and Financial Condition" for the Q1 2021 period.
  • 4Investors are directed to the press release for specific financial metrics, such as revenue and earnings.
  • 5This 8-K serves as official notification of the Q1 2021 financial results announcement.
  • 6The information is furnished under Item 2.02 and is not considered 'filed' for certain regulatory purposes, meaning it doesn't automatically trigger liabilities under Section 18 of the Exchange Act.
  • 7An interactive data file in Inline XBRL format is also provided as part of the filing.

Frequently Asked Questions

The specific financial results for the quarter ended March 31, 2021, are detailed in the press release furnished as Exhibit 99.01 to this 8-K filing. You should refer to that document for detailed figures on revenue, earnings, and other financial metrics.

No, the information in this Item 2.02 is furnished pursuant to Item 2.02 of Form 8-K and is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it automatically incorporated by reference into other DexCom filings unless explicitly stated.

The main purpose of this 8-K filing is to officially announce and provide access to DexCom's financial results for the first quarter of 2021, which were released via a press announcement on the same day.

This 8-K filing itself does not contain forward-looking guidance. However, the accompanying press release (Exhibit 99.01) typically includes such information. Investors should review the press release for any guidance or outlook provided by the company.